European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer (Q63592591)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer |
clinical trial |
Statements
EUDARIO (English)
0 references
A Multicentre, Open-label, Three-arm Randomised Phase II Trial Assessing the Safety and Efficacy of the HSP90 Inhibitor Ganetespib in Combination With Carboplatin Followed by Maintenance Treatment With Niraparib Versus Ganetespib Plus Carboplatin Followed by Ganetespib and Niraparib Versus Carboplatin in Combination With Standard Chemotherapy Followed by Niraparib Maintenance Treatment in Platinum-sensitive Ovarian Cancer Patients (English)
0 references
30 November 2018
0 references
31 March 2021
0 references
120
0 references
18 year
0 references